One of the most controversial proposed disorders for the upcoming revision of psychiatry’s billing bible of mental disorders, (the DSM-5) is Psychosis Risk Syndrome (PRS) a “mental disorder” that, if voted into DSM, would confirm the allegations that psychiatry is manufacturing a Brave New World for itself—heavily backed by Big Pharma—of drugging children before they develop a “mental illness.”
A lawsuit filed last week accuses Johnson & Johnson of conspiring with pharmaceutical consultant Omnicare in an effort to push J&J drugs on nursing home residents, and violating federal Medicaid laws in the process. As a result of the scheme, “residents were overcharged for their medications, had additional medications administered and were unlawfully switched to Johnson & Johnson drugs,” all in the name of increasing revenue, according to the lawsuit.
Children as young as one are being prescribed powerful anti-psychotic drugs that have been linked to deaths overseas. The strong medication is designed to quell psychotic episodes normally experienced by adults with schizophrenia and bi-polar. There are concerns some doctors are illegitimately writing scripts for pre-schoolers and primary school children for unapproved medical reasons, such as behavioural problems or ADHD.
CHILDREN as young as two are being prescribed anti-psychotic drugs that have been linked to deaths overseas. Almost 2000 children aged under 18 were prescribed the drugs in Victoria in 2007-08.
Who is Patrick McGorry and what does he promote? He’s a psychiatrist just named Australian of the Year for his work in “youth mental health reform.” What does that reform consist of? What he calls a “new form of climate change.” It sure is. He not only promotes youths being put on antipsychotics and antidepressants, cited by international drug regulatory agencies as causing hallucinations, hostility, personality change, life-threatening diabetes, strokes, suicide and death, McGorry goes a giant step further—drug them before they’ve even developed a “psychiatric” disorder. The Association for the Accreditation of Human Research Protection Programs (AHRPP) likens such concepts to “performing mastectomies on women who are at risk of—but do not have—breast cancer.”